The Misuse of Medications in Nursing Homes
Tell us how we can help.
Thank you for sending us a message!
For immediate concerns, you may reach our customer and sales support at +1 (866) 710 1018 or email us at sales@base10genetics.com +1 (866) 710 1018 sales@base10genetics.com info@base10genetics.com +1 (866) 710 1018 Patient Portal Pharmacists Login LTC Administrators/Providers More on Infection Control Medical/Healthcare Facilities Corporate Pharmacies More on Genomics Corporate Pharmacy Long-Term Care Facilities About Us PlexusDX Resources News and Articles Careers Events Medical/Healthcare Facilities Corporate Pharmacies More on Infection Control Corporate Pharmacy Long-Term Care Facilities More on Genomics About Us PlexusDX Resources News and Articles Careers Events Contact Us Contact Us
As part of its commitment to advance health equity by improving the safety and quality of nursing facility residents and staff, the Biden administration has teamed up with the Centers for Medicare & Medicaid Services (CMS) to investigate the issue of overprescription of antipsychotic medications by hospital physicians in nursing homes.
According to a recent study by the New York Times, 21% of nursing home residents were taking antipsychotic drugs. Some clinicians believe that physicians bear responsibility for overprescribing, while others think that change will come from more academic research in the scientific community.
Stock photo from elements.envato.com
CMS has partnered with nursing homes, as well as other federal and state organizations, to discover better ways to use non-pharmacological methods in treating conditions that require medication.
At BASE10, we utilize proprietary, data-driven technology and software management systems to help clinicians identify medications that may be improperly prescribed, with the goals of deprescribing and adverse event reduction in mind.
As just one example, we use Pharmacogenomics (PGx) to study how genetic variations can affect a person’s response to drugs, and whether they’re likely to experience adverse side effects or receive the proper therapeutic benefit from treatment.
We make it a priority to use thoroughly-researched evidence to deliver PGx results to the patient’s prescribing physician. In accordance with FDA labelling, CPIC guidelines, and other rigorously researched sources, we’ve created a list of 100+ drug-gene pairs that have pharmacogenetic associations. By incorporating PGx into our MTM platform, the patient’s pharmacist is then able to discuss both genetic and nongenetic findings with the prescribing physician to make sure their patients get the best possible care.
This high-touch clinical engagement platform delivers applicable PGx results as well as non-genetics-informed clinical interventions directly to the patient’s care team, utilizing a cost-effective and time-sensitive method that aims to reduce morbidity, mortality, and costs associated with the “one-size-fits-all” approach to disease treatment and prevention.
high-touch clinical engagement platform Source: https://www.nytimes.com/2021/09/11/health/nursing-homes-schizophrenia-antipsychotics.html https://www.nytimes.com/2021/09/11/health/nursing-homes-schizophrenia-antipsychotics.html
Sign up and join us for BASE10’s upcoming webinar on Thursday, July 28th at 1PM CST: “Understanding Cardiovascular Disease Through a Different Lens with Precision Medicine.”
Sign up “Understanding Cardiovascular Disease Through a Different Lens with Precision Medicine.”
-1.png?width=900&name=Live%20Webinar%20(1)-1.png)
About BASE10 Genetics
Located in Chicago, BASE10 is a healthcare software technology company whose platform creates turnkey disease management programs that can be deployed at scale for nursing home operators, pharmacies, payors, and self-funded employers.
Tags
Other articles you might like
June 8: Weekly Long-Term Care News and Updates
Common autoimmune drugs reduce mortality, up clinical status in COVID-19: NIH Dr. Irene Hamrick’s Updates: June 2
COVID & Booster Dose For Children: · The FDA provided EUA to expand eligibility for …
Dr. Irene Hamrick’s Updates: June 2
COVID & Booster Dose For Children: · The FDA provided EUA to expand eligibility for …
Infection Control Precision Nutrition Precision Medication Schedule a Demo Patient Login Pharmacist Login LTC Portal About Us Plexus DX Resources News and Articles Careers Events Privacy Policy Terms of Use